Discover most of the FDA-approved drugs from the medical speciality of Neurology. This page can serve as a valuable information guide for healthcare providers and patients seeking detailed drug ...
(Reuters) - Johnson & Johnson said on Monday it would buy neurological drug maker Intra-Cellular Therapies for $14.6 billion, its biggest deal in more than two years, boosting its presence in the ...
Berg, M. J. What's the problem with generic antiepileptic drugs?: a call to action. Neurology 68, 1245–1246 (2007). Article Google Scholar Gidal, B. E. Bioequivalence of antiepileptic drugs ...
Drugs acting on the cholinergic system can improve or worsen cognitive abilities, and their effects are particularly pronounced in frail elderly individuals and patients with Alzheimer disease.
(Reuters) - Johnson & Johnson said on Monday it would buy neurological drug maker Intra-Cellular Therapies for $14.6 billion, its biggest deal in more than two years, boosting its presence in the ...
With a sweep of the pen, President Donald Trump has ended a Biden administration effort to lower the cost of prescription drugs for people on Medicare and Medicaid.